Clozapine rechallenge after myocarditis

Australasian Psychiatry

Volumn 17, Issue 5, 2009, Pages 421-422

  Jayathilake, Indika ^a   Singh, Ashok Kumar ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN; CLOZAPINE; TROPONIN;

ADULT; CARDIOTOXICITY; CASE REPORT; CLINICAL FEATURE; DISEASE COURSE; DRUG DOSE INCREASE; DRUG INDUCED DISEASE; DRUG MECHANISM; DRUG WITHDRAWAL; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAM; HOSPITAL PATIENT; HUMAN; LETTER; MALE; MYOCARDITIS; PARANOID SCHIZOPHRENIA; PROTEIN BLOOD LEVEL; PROVOCATION TEST;

ADULT; CLOZAPINE; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; MALE; MYOCARDITIS; RETREATMENT; TROPONIN I;

EID: 70849103678     PISSN: 10398562     EISSN: 14401665     Source Type: Journal    
DOI: 10.1080/10398560902965302     Document Type: Letter

References (4)

1. Kirpekar VC, Deshpande SM, Joshi PP. Reversible myocarditis in a patient receiving clozapine. Indian Heart Journal 2001; 53: 779-781.
2. Killian JG, Kerr K, Lawrence C, Celermajer DS. Myocarditis and cardiomyopathy associated with clozapine. Lancet 1999; 354: 1841-1845.
3. Reinders J, Parsonage W, Lange D et al. Clozapinerelated myocarditis and cardiomyopathy in an Australian metropolitan psychiatric service. Australian and New Zealand Journal of Psychiatry 2004; 38: 915-922.
4. Reid P. Clozapine rechallenge after myocarditis [letter]. Australian and New Zealand Journal of Psychiatry 2001; 35: 249.